TRACY RAPP: Open Payments
NPI 1720451545 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 42 payments from 15 companies in 2025. Trend: 2023 $1,667 · 2024 $2,560 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $150 |
| Theratechnologies Inc. | 4 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Lilly USA, LLC | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $69 |
| ViiV Healthcare Company | 3 | $65 |
| Astellas Pharma US Inc | 2 | $63 |
| Novo Nordisk Inc | 3 | $63 |
| ABBVIE INC. | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $43 |
Products named: EGRIFTA, PIFELTRO, Veozah, MOUNJARO, AIRSUPRA, TRELEGY ELLIPTA, Wegovy, QULIPTA.
Industry payments across TN — which companies pay providers there.
